Voyager Therapeutics Inc
Company Overview
Voyager Therapeutics is a gene therapy company focused on developing life-changing treatments for severe neurological diseases. The company utilizes its proprietary adeno-associated virus (AAV) platform to develop targeted gene therapies. Their primary focus is on diseases such as Parkinson's disease, Huntington's disease, and other severe neurological conditions.
The company's business model is centered around research, development, and potential commercialization of gene therapy treatments. They also generate revenue through strategic collaborations and licensing agreements with other pharmaceutical companies.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $24.63m | $38.41m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $29.58m | $44.6m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $19.52m | $35.7m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Voyager Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.